» Articles » PMID: 39641247

Diagnostic Value of Plasma Long Non-coding SLC26A4 Antisense RNA 1 Combined with Magnetic Resonance Imaging in Rectal Cancer

Overview
Publisher Aves
Specialty Gastroenterology
Date 2024 Dec 6
PMID 39641247
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: The prevalence of rectal cancer is increasing every year due to changes in living and eating habits. Early diagnosis contributes to the treatment and survival of patients. This study investigated the feasibility of employing SLC26A4-AS1 combined with magnetic resonance imaging (MRI) for diagnosing rectal cancer.

Materials And Methods: The current study involved 125 patients with rectal cancer and an equal number of healthy individuals. The study focused on assessing the relationship between SLC26A4-AS1 expression and clinical data among patients with rectal cancer by analyzing the expression levels. MRI blood perfusion parameters (Ktrans, Kep, Ve, and incremental area under the curve (iAUC)) were measured in the patients with rectal cancer. The regulation of SLC26A4-AS1 on the biological function of rectal cancer cells was analyzed by Cell Counting Kit-8 (CCK-8) method, flow cytometry, and Transwell assay. Furthermore, luciferase activity assays and RNA-binding protein immunoprecipitation assay (RIP) were conducted to elucidate the relationship between SLC26A4-AS1 and microRNA-3174 (miR-3174).

Results: A significant reduction in SLC26A4-AS1 expression was observed in rectal cancer alongside a significant increase in miR-3174 levels. SLC26A4-AS1 expression was negatively correlated with Ktrans and Kep values, but not with Ve or iAUC values. Cell experiments confirmed the inhibitory effect of SLC26A4-AS1 overexpression on the growth of rectal cancer cells. Additionally, SLC26A4-AS1 sponged miR-3174 mediated the progression of rectal cancer. The enriched miR-3174 may counteract the suppression of the biological activity of oe-SLC26A4-AS1 on rectal cancer cells.

Conclusion: SLC26A4-AS1 may serve as a diagnostic tool for rectal cancer, mediating tumor progression by directly targeting miR-3174.

References
1.
Guan Y, Li Y, Yang Q, Yu J, Qiao H . LncRNA ABCC6P1 promotes proliferation and migration of papillary thyroid cancer cells via Wnt/β-catenin signaling pathway. Ann Transl Med. 2021; 9(8):664. PMC: 8106106. DOI: 10.21037/atm-21-505. View

2.
Basendowah M, Ezzat M, Khayyat A, Alamri E, Madani T, Alzahrani A . Comparison of flexible endoscopy and magnetic resonance imaging in determining the tumor height in rectal cancer. Cancer Rep (Hoboken). 2023; 6(2):e1705. PMC: 9939992. DOI: 10.1002/cnr2.1705. View

3.
Si J, Ma Y, Lv C, Hong Y, Tan H, Yang Y . HIF1A-AS2 induces osimertinib resistance in lung adenocarcinoma patients by regulating the miR-146b-5p/IL-6/STAT3 axis. Mol Ther Nucleic Acids. 2021; 26:613-624. PMC: 8517096. DOI: 10.1016/j.omtn.2021.09.003. View

4.
Li M, Xu X, Xia K, Jiang H, Jiang J, Sun J . Comparison of Diagnostic Performance between Perfusion-Related Intravoxel Incoherent Motion DWI and Dynamic Contrast-Enhanced MRI in Rectal Cancer. Comput Math Methods Med. 2021; 2021:5095940. PMC: 8346302. DOI: 10.1155/2021/5095940. View

5.
Ao W, Zhang X, Yao X, Zhu X, Deng S, Feng J . Preoperative prediction of extramural venous invasion in rectal cancer by dynamic contrast-enhanced and diffusion weighted MRI: a preliminary study. BMC Med Imaging. 2022; 22(1):78. PMC: 9052632. DOI: 10.1186/s12880-022-00810-9. View